CrossrefInfokarte
Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses
PharmacoEconomics - Open · 2024-11 · 8 (6) · 823-836
DOI: 10.1007/s41669-024-00511-9 ↗Abstract
Kein Abstract verfügbar.
EUVIMED